Press Center

The new review of the most notable patents disputes in Life Sciences in EAEU and CIS.

• pdf, 5.00 Mb

Lidings invites you to a seminar on the hottest and most striking amendments to labor legislation — as bright as autumn bonfires.

Vladislav Ryabov has been a member of the Lidings team since 2021. Over this time, he has established himself as one of the firm's leading experts in intellectual property protection. In his new role as Counsel, Vladislav will focus on further developing the firm's litigation practice in complex disputes concerning trademarks, patents, and unfair competition, strengthening Lidings' position in the IP market.

On August 4, 2026, the President of the Russian Federation signed Federal Constitutional Law No. 3‑FKZ of August 4, 2026, “On Amending Article 19 of the Federal Constitutional Law ‘On the Judicial System of the Russian Federation’ and Article 5 of the Federal Constitutional Law ‘On the Supreme Court of the Russian Federation’” (hereinafter – the “Law”)[1].

The Russian Government has submitted to the State Duma a draft law proposing to regulate the procedure for reducing the remuneration payable to court-appointed experts in civil, commercial and administrative proceedings.

The draft law has been prepared in furtherance of Ruling No. 6-P of the Constitutional Court of the Russian Federation dated 11 February 2026, in which the Constitutional Court of the Russian Federation indicated the need to establish criteria for the permissible reduction of an expert’s remuneration previously agreed and approved by the court.

The Ministry of Justice of Russia has prepared the draft federal law “On Amendments to Article 477 of Part Two of the Civil Code of the Russian Federation”. The draft law was prepared in order to implement Ruling No. 38-P of the Constitutional Court of the Russian Federation dated 9 June 2026 which declared paragraph 2 of Article 477 of the Civil Code of the Russian Federation unconstitutional to the extent that it creates uncertainty as to whether a buyer may bring court claims after the expiry of the two-year period for discovering defects, provided that the defects themselves were identified within that period.

Russian pharmaceutical manufacturers are increasingly looking toward the GCC and MENA regions. But "entering" and "establishing a foothold" are challenges of entirely different magnitudes.

The two key markets in the region — the UAE and Saudi Arabia — despite their undeniable appeal, require fundamentally different approaches.

Together with the Pharvestnik Magazine, Julia Kuzmenko, Counsel and Head of Regulatory Practice at Lidings, examined the nuances of the regulatory architecture in these two jurisdictions.

On 24 August 2026, Decree of the President of the Russian Federation No. 604 “On Measures to Ensure the Security of Critical Infrastructure Facilities of the Russian Federation” (the Decree) was published and entered into force. The Decree empowers the Government of the Russian Federation, acting upon an instruction of the President, to introduce temporary administration over business entities connected with critical infrastructure facilities.

Lidings' lawyers have prepared a review following the Roskomnadzor "Open Day" held on 14 August 2026, and have compiled the regulator's responses to practical questions from personal data operators. Below are the key findings from the event.

The study presents a comparative legal analysis of the regulation of artificial intelligence ("AI"), with a focus on judicial practice in three post-Soviet states — Russia, Belarus, and Kazakhstan.

• pdf, 379.23 kb